[Federal Register Volume 84, Number 28 (Monday, February 11, 2019)]
[Notices]
[Pages 3205-3206]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01740]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 3206]]

amended, notice is hereby given of the joint meeting of the National 
Cancer Advisory Board (NCAB) and NCI Board of Scientific Advisors 
(BSA).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (http://videocast.nih.gov).
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
section 552b(c)(6), Title 5 U.S.C., as amended, for the review, 
discussion, and evaluation of individual intramural programs and 
projects conducted by the National Cancer Institute, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Open: December 2, 2019, 8:30 a.m. to 4:45 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors, NCI Director's report and 
presentations, NCI Board of Scientific Advisors Concepts Review.
    Closed: December 2, 2019, 5:00 p.m. to 6:00 p.m.
    Agenda: Review of intramural program site visit outcomes and the 
discussion of confidential personnel issues.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Room TE406 & 408, Rockville, MD 20850.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, Room 
7W444, Bethesda, MD 20892, 240-276-6340, [email protected].

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Open: December 3, 2019, 9:00 a.m. to 12:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors, and NCI Board of Scientific 
Advisors Concepts Review.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Room TE406 & 408, Rockville, MD 20850.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, Room 
7W444, Bethesda, MD 20892, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NCI-Shady Grove campus. All 
visitors will be asked to show one form of identification (for 
example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit.
    Information is also available on the Institute's/Center's home 
page: NCAB: http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm, BSA: 
http://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 5, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-01740 Filed 2-8-19; 8:45 am]
 BILLING CODE 4140-01-P